Recovering Financially from COVID-19

The COVID-19 pandemic had a dramatic impact on the finances of Michigan Medicine and the entire University of Michigan. Leadership at Michigan Medicine has made tough decisions to create an economic recovery plan that includes non-essential expense reduction, a hiring freeze, a salary freeze, leadership salary reductions, furloughs and reductions in force, and a one-year suspension of Michigan Medicine's retirement match for employees. All capital projects that are not required for safety or regulatory compliance, including the new inpatient hospital, have been paused until further notice. Although we don't know how the pandemic will unfold, Michigan Medicine leadership promises that any future decisions about the economic recovery plan will be guided by Michigan Medicine's core missions of patient care, research, and education. 

More Articles About: covid Covid-19 coronavirus pandemic economic recovery plan financial recovery
Featured News & Stories green circle cells close together highlighted in yellow
Health Lab
Solving a sticky, life threatening problem
Michigan Medicine researchers have zeroed in on C. auris’ uncanny ability to stick to everything from skin to catheters and made a startling discovery.
 Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory
The Long-Term Care Data Cooperative: Your One Stop Shop for Nursing Home Data
In this episode, Donovan & Matt talk with health services researcher Betsy White from Brown University about a unique new resource for researchers called the Long-Term Data Cooperative, a provider-led data sharing collaboratory that puts together nursing home EHR data from EHR vendors that can be linked to Medicare claims. This powerful tool is made available to researchers through an online application process.
 Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
Could Prostate Cancer Drugs Help Fight COVID Infections?
Researchers look into a drug called proxalutamide as a potential therapeutic for the coronavirus.
 pill attacking coronavirus
Health Lab
Prostate cancer drug shows promise against COVID
Michigan Medicine researchers looked into a drug in development to treat prostate cancer called proxalutamide, which works by blocking an enzyme called TMPRSS2 (transmembrane protease, serine 2) that is regulated by androgen receptors, as a potential therapeutic for COVID.
 nasal spray
Health Lab
An adjuvanted intranasal vaccine for COVID-19 protects both young and old mice
A collaborative research effort led by the University of Michigan and the Icahn School of Medicine at Mount Sinai has resulted in a nasal vaccine adjuvant that stops infection in both young and old mice.
 The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Good collaborators are why I stayed
An interview with Dr. Steven Kunkel on research at U-M Medical School.